{
    "Trade/Device Name(s)": [
        "ARCHITECT Cortisol",
        "ARCHITECT Cortisol Calibrators"
    ],
    "Submitter Information": "Seradyn, Inc",
    "510(k) Number": "K062204",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033731"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFT",
        "JIT"
    ],
    "Summary Letter Date": "October 19, 2006",
    "Summary Letter Received Date": "August 3, 2006",
    "Submission Date": "July 31, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1205",
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "Cortisol (hydrocortisone and hydroxycorticosterone) test system",
        "Cortisol (calibrator) test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Cortisol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System",
        "ARCHITECT i2000",
        "ARCHITECT i2000SR"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Cortisol CMIA assay and calibrators for quantitative cortisol measurement in serum, plasma, or urine for diagnosis and treatment of adrenal disorders.",
    "Indications for Use Summary": "Quantitative determination of cortisol in human serum, plasma, or urine to aid in diagnosis and treatment of adrenal disorders; calibrators for calibration of the ARCHITECT i System.",
    "fda_folder": "Clinical Chemistry"
}